<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR9">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jakubowiak</surname>
    <given-names>AJ</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma</article-title>
  <source>Blood</source>
  <year>2012</year>
  <volume>120</volume>
  <fpage>1801</fpage>
  <lpage>1809</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2012-04-422683</pub-id>
  <?supplied-pmid 22665938?>
  <pub-id pub-id-type="pmid">22665938</pub-id>
 </element-citation>
</ref>
